Baroque Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Baroque Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $1.9M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Baroque Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.9M Trade | TransData Nexus

Baroque Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $1.9M Total Trade · DGFT Verified

Baroque Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.9M across 2 products in 2 therapeutic categories. Based on 47 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Melatonin ($1.7M), Bromhexine ($218.0K), .

Baroque Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Baroque Pharmaceuticals Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Baroque Pharmaceuticals Private Limited? — Company Overview & Market Position

Baroque Pharmaceuticals Private Limited, established on November 23, 1993, is a privately held pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. As of March 2026, Baroque Pharmaceuticals has an authorized capital of ₹5.27 crore and a paid-up capital of ₹1.68 crore. The company employs between 200 and 500 staff members, reflecting its substantial presence in the pharmaceutical industry. (clodura.ai) Baroque Pharmaceuticals operates under the Corporate Identification Number (CIN) U24230GJ1993PTC020695, as registered with the Registrar of Companies, Ahmedabad. The company's official website is www.baroquepharma.com, providing comprehensive information about its products and services.

What Does Baroque Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Melatonin$1.7M 2Bromhexine

Product Portfolio — Top 2 by Export Value

Baroque Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Melatonin	Nutritional Supplements	$1.7M	34	14.9%	2
2	Bromhexine	Respiratory & OTC	$218.0K	13	1.3%	15

Baroque Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $1.9M. The top category is Nutritional Supplements (88.6% of portfolio), followed by Respiratory & OTC (11.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Baroque Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Baroque Pharmaceuticals operates multiple manufacturing facilities in India, with the primary plant located in Khambhat, Gujarat. This facility is approved by various regulatory authorities from Africa, South Asia, CIS, Latin America, Southeast Asia, Central Asia, and the Middle East. The company has undertaken assignments to obtain higher regulatory approvals, aiming to enhance its global market presence. Additionally, Baroque Pharmaceuticals has a manufacturing unit in Nigeria, further expanding its production capabilities. The facilities are certified by WHO-GMP and EU-GMP, ensuring compliance with international quality standards.

3Key Leadership

The leadership team at Baroque Pharmaceuticals is spearheaded by Chairman and Managing Director Mr. J.D. Patel, who has over 43 years of technical and strategic experience in the pharmaceutical industry. Other key executives include Mr. Lalit Saraswat, Director, with over 30 years of experience, and Mr. Pragnesh J. Patel, Director, possessing more than 20 years in the field. Mr. Jignesh Patel, Director, brings over 25 years of medical practice experience to the team. This diverse and experienced leadership team drives the company's strategic direction and operational excellence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Baroque Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Baroque Pharmaceuticals has established a significant presence in various regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facilities are approved by regulatory authorities from these regions, facilitating market access and compliance with stringent quality standards. Baroque Pharmaceuticals has undertaken assignments to obtain higher regulatory approvals, aiming to enhance its global market presence. The company's commitment to quality and compliance is further demonstrated by its WHO-GMP and EU-GMP certifications, which are essential for market access in these regions.

2Emerging Markets

Baroque Pharmaceuticals has expanded its footprint into emerging markets across Africa, Latin America, and Southeast Asia. The company's manufacturing facilities are approved by various regulatory authorities from these regions, facilitating market access and compliance with local standards. Additionally, Baroque Pharmaceuticals has undertaken assignments to obtain higher regulatory approvals, aiming to enhance its global market presence. The company's commitment to quality and compliance is further demonstrated by its WHO-GMP and EU-GMP certifications, which are essential for market access in these regions.

Geographic Strategy

Baroque Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Baroque Pharmaceuticals' manufacturing facilities are approved by various regulatory authorities, including those from the United States. The company's commitment to obtaining higher regulatory approvals underscores its strategic direction to enhance global market access and competitiveness. Baroque Pharmaceuticals' focus on quality manufacturing and compliance with international standards further strengthens its strategic position in the global pharmaceutical industry.

2WHO & EU GMP

Baroque Pharmaceuticals' manufacturing facilities are certified by WHO-GMP and EU-GMP, ensuring compliance with international quality standards. These certifications are essential for market access in regulated markets and reflect the company's commitment to quality manufacturing. The company's focus on obtaining higher regulatory approvals further demonstrates its dedication to enhancing global market presence and competitiveness.

3CDSCO & Indian Regulatory

Baroque Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Baroque Pharmaceuticals operates in a competitive landscape, with several key players in the pharmaceutical industry offering similar products. The company's focus on quality manufacturing, as evidenced by its WHO-GMP and EU-GMP certifications, positions it favorably in the market. Additionally, Baroque Pharmaceuticals' commitment to obtaining higher regulatory approvals demonstrates its strategic direction to enhance global market access and competitiveness. The company's diversified geographic presence across India, Africa, Latin America, Southeast Asia, and select developed markets further mitigates concentration risk and positions it to leverage growth opportunities in various regions.

2Key Differentiators

Baroque Pharmaceuticals' key differentiators include its commitment to quality manufacturing, as evidenced by its WHO-GMP and EU-GMP certifications, and its strategic focus on obtaining higher regulatory approvals to enhance global market access. The company's diversified geographic presence across India, Africa, Latin America, Southeast Asia, and select developed markets further mitigates concentration risk and positions it to leverage growth opportunities in various regions. Additionally, Baroque Pharmaceuticals' focus on providing cost-effective medicines to the global population underscores its dedication to improving global health.

Strategic Position

Buyer Due Diligence Brief — Evaluating Baroque Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Baroque Pharmaceuticals has demonstrated a consistent track record in pharmaceutical manufacturing, with a focus on quality and compliance with international standards. The company's manufacturing facilities are approved by various regulatory authorities, including those from India, Africa, South Asia, CIS, Latin America, Southeast Asia, Central Asia, and the Middle East. Baroque Pharmaceuticals' commitment to obtaining higher regulatory approvals underscores its strategic direction to enhance global market access and competitiveness. The company's diversified geographic

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Baroque Pharmaceuticals Private Limited

How many pharmaceutical products does Baroque Pharmaceuticals Private Limited export from India?

Baroque Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Melatonin ($1.7M), Bromhexine ($218.0K). Total export value is $1.9M.

What is Baroque Pharmaceuticals Private Limited's total pharmaceutical export value?

Baroque Pharmaceuticals Private Limited's total pharmaceutical export value is $1.9M, based on 47 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Baroque Pharmaceuticals Private Limited cover?

Baroque Pharmaceuticals Private Limited exports across 2 therapeutic categories. The largest are Nutritional Supplements (88.6%, 1 products), Respiratory & OTC (11.4%, 1 products).

Get Full Baroque Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.